Module - Haematological Malignancies 2 (SLS431)
STP
Clinical experiential learning is the range of activities trainees may undertake in order to gain the experience and evidence to demonstrate their achievement of module competencies and assessments. The list is not definitive or mandatory, but training officers should ensure, as best training practice, that trainees gain as many of these clinical experiences as possible. They should be included in training plans, and once undertaken they should support the completion of module assessments and competencies within the e-portfolio.
Clinical experiential learning
- Attend multidisciplinary team meetings in myeloid and lymphoid malignancies at which the results of the molecular investigations are discussed, along with other laboratory and clinical information Reflect on the impact of the laboratory investigations on patient treatment and management
- Attend ‘leukemia’ and/or ‘lymphoma’ clinics and review the work of the clinics and interaction with other disciplines
- Identify the main clinical and haematological symptoms associated with myeloid malignancies, CLL and large B cell lymphomas
- Attend a follow up appointment and reflect on the different types of treatment available for patients with myeloid malignancies, CLL or large B cell lymphomas
- Visit a clinical trials unit and discuss the importance of trials in the development of new treatments for patients Observe and reflect on the techniques used for flow cytometry assessment of acute myeloid leukaemia and CLL
- Observe the preparation and analysis of G-banded chromosomes in the relevant disorders Reflect on the clinically significant chromosome rearrangements that are commonly detected